Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Somponnat, Sampattavanich"'
Autor:
Chanida Thinyakul, Yasuhisa Sakamoto, Mayuko Shimoda, Yanliang Liu, Suyanee Thongchot, Omnia Reda, Akihiro Nita, Romgase Sakamula, Somponnat Sampattavanich, Ayato Maeda, Paweenapon Chunthaboon, David Nduru, Mayumi Niimura, Yohei Kanamori, Peti Thuwajit, Keiichi I. Nakayama, Kun-Liang Guan, Yorifumi Satou, Chanitra Thuwajit, Toshiro Moroishi
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-15 (2024)
Abstract Cancer cells adeptly manipulate the tumor microenvironment (TME) to evade host antitumor immunity. However, the role of cancer cell-intrinsic signaling in shaping the immunosuppressive TME remains unclear. Here, we found that the Hippo pathw
Externí odkaz:
https://doaj.org/article/78c73de30af2440f83df06f6fbe4a097
Autor:
Saowanee Jeayeng, Malinee Saelim, Phetthinee Muanjumpon, Pongsakorn Buraphat, Potjanee Kanchanapiboon, Somponnat Sampattavanich, Uraiwan Panich
Publikováno v:
Cells, Vol 13, Iss 19, p 1661 (2024)
The skin microenvironment created by keratinocytes (KC) influences the stress responses of melanocytes (MC) to UVB insults. This study employed RNA sequencing analysis as well as in vitro and in vivo models to elucidate the underlying mechanisms. Our
Externí odkaz:
https://doaj.org/article/9de7f24b672b44a6ae10cde8e3d5f4d2
Autor:
Monthira Suntiparpluacha, Jantappapa Chanthercrob, Doonyapat Sa-nguanraksa, Juthamas Sitthikornpaiboon, Amphun Chaiboonchoe, Patipark Kueanjinda, Natini Jinawath, Somponnat Sampattavanich
Publikováno v:
PeerJ, Vol 11, p e15350 (2023)
Background Triple-negative breast cancer (TNBC) is a rare and aggressive breast cancer subtype. Unlike the estrogen receptor-positive subtype, whose recurrence risk can be predicted by gene expression-based signature, TNBC is more heterogeneous, with
Externí odkaz:
https://doaj.org/article/22a3104897434dce94af55093751b24f
Autor:
Nut Pipatpanyanugoon, Nicha Wareesawetsuwan, Sunisa Prasopporn, Wannapan Poolex, Trairak Pisitkun, Worasak Kaewkong, Somponnat Sampattavanich, Siwanon Jirawatnotai
Publikováno v:
Cancer Communications, Vol 42, Iss 1, Pp 75-79 (2022)
Externí odkaz:
https://doaj.org/article/6cad8ebe0d1b438e8f68ab2b777e41b5
Autor:
Sunisa Prasopporn, Orawan Suppramote, Ben Ponvilawan, Chanette Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat, Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Siwanon Jirawatnotai
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Externí odkaz:
https://doaj.org/article/ec0a8457396d49cb9b31dd5bb0eb9d12
Autor:
Sunisa Prasopporn, Orawan Suppramote, Ben Ponvilawan, Chanette Jamyuang, Jantappapa Chanthercrob, Amphun Chaiboonchoe, Pimkanya More-Krong, Kamonchanok Kongsri, Monthira Suntiparpluacha, Rawisak Chanwat, Krittiya Korphaisarn, Seiji Okada, Somponnat Sampattavanich, Siwanon Jirawatnotai
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Cholangiocarcinoma (CCA) is a highly lethal gastrointestinal malignancy that has one of the worst prognoses among solid tumors. The combination of Gemcitabine + Cisplatin (GEM/CIS) remains the standard first-line treatment for advanced stage CCA. How
Externí odkaz:
https://doaj.org/article/911c30605c684512880a37fea8fa7666
Autor:
Supawan Jamnongsong, Patipark Kueanjinda, Pongsakorn Buraphat, Phuwanat Sakornsakolpat, Kulthida Vaeteewoottacharn, Seiji Okada, Siwanon Jirawatnotai, Somponnat Sampattavanich
Publikováno v:
iScience, Vol 25, Iss 10, Pp 105182- (2022)
Summary: Cholangiocarcinoma (CCA) is rare cancer with the highest incidence in Eastern and Southeast Asian countries. Advanced CCA patients rely on chemotherapeutic regimens that offer unsatisfied clinical outcomes. We developed a comprehensive drug
Externí odkaz:
https://doaj.org/article/bc67eff8802b4468863fc4fbb1e529b5
Autor:
Orawan Suppramote, Sunisa Prasopporn, Satinee Aroonpruksakul, Ben Ponvilawan, Jiradej Makjaroen, Monthira Suntiparpluacha, Krittiya Korphaisarn, Komgrid Charngkaew, Rawisak Chanwat, Trairak Pisitkun, Seiji Okada, Somponnat Sampattavanich, Siwanon Jirawatnotai
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Cholangiocarcinoma (CCA) is one of the most difficult to treat cancers, and its nature of being largely refractory to most, if not all, current treatments results in generally poor prognosis and high mortality. Efficacious alternative therapies that
Externí odkaz:
https://doaj.org/article/32d7094c80a14ff6b0f96ff7b44b09d6
Autor:
Pimkwan Jaru-ampornpan, M.D., Chottiwat Tansirisithikul, M.D., Manachaya Prukajorn, M.D., Somponnat Sampattavanich, Ph.D., Manop Pithukpakorn, M.D.
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 23, Iss , Pp 101189- (2021)
Purpose: To report a case of aggressive infantile orbital embryonal rhabdomyosarcoma harboring germline ATM mutation and 2 somatic mutations as revealed by next-generation sequencing and the potential application for personalized therapy. Observation
Externí odkaz:
https://doaj.org/article/75213027c676409f8a30462f78211a4d
Autor:
Kriengkrai Phongkitkarun, Porncheera Chusorn, Maliwan Kamkaew, Eric W.-F. Lam, Chamras Promptmas, Somponnat Sampattavanich
Forkhead box protein M1 (FOXM1) is a proliferation-associated transcription factor contributing to the G2/M phase transition of the cell cycle. Although the upregulation of FOXM1 has been observed in different cancer types, how the regulation of FOXM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c86e042b0aff89f9fdda09886ec59907
https://doi.org/10.1101/2023.03.01.530713
https://doi.org/10.1101/2023.03.01.530713
